Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Visual quality assessment of the liver graft by the transplanting surgeon predicts postreperfusion syndrome after liver transplantation: a retrospective cohort study.

Kork F, Rimek A, Andert A, Becker NJ, Heidenhain C, Neumann UP, Kroy D, Roehl AB, Rossaint R, Hein M.

BMC Anesthesiol. 2018 Mar 9;18(1):29. doi: 10.1186/s12871-018-0493-9.

2.

Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience.

Benkö T, Hoyer DP, Saner FH, Treckmann JW, Paul A, Radunz S.

Transplant Direct. 2017 Oct 18;3(11):e224. doi: 10.1097/TXD.0000000000000738. eCollection 2017 Nov.

3.

Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.

Liebig M, Hassanzada A, Kämmerling M, Genz B, Vollmar B, Abshagen K.

Exp Biol Med (Maywood). 2018 Jan;243(1):1-12. doi: 10.1177/1535370217738730. Epub 2017 Oct 24.

PMID:
29065724
4.

The impact of donor liver graft quality on postoperative outcome in liver transplant recipients. A single centre experience.

Tomescu D, Popescu M, Jipa L, Fota R, Ungureanu D, Zamfir R, Orban C, Dima SO, Popescu I.

Rom J Anaesth Intensive Care. 2016 Apr;23(1):19-26. doi: 10.21454/rjaic.7518.231.gft.

5.

Resolution of donor non-alcoholic fatty liver disease following liver transplantation.

Posner AD, Sultan ST, Zaghloul NA, Twaddell WS, Bruno DA, Hanish SI, Hutson WR, Hebert L, Barth RN, LaMattina JC.

Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13032. Epub 2017 Jul 13.

6.

Novel technology for liver regeneration and replacement.

Wertheim JA.

Liver Transpl. 2016 Nov;22(S1):41-46. doi: 10.1002/lt.24635. No abstract available.

7.

Auxiliary partial liver transplantation for acute liver failure using "high risk" grafts: Case report.

Duan WD, Wang XT, Wang HG, Ji WB, Li H, Dong JH.

World J Gastroenterol. 2016 Feb 7;22(5):1919-24. doi: 10.3748/wjg.v22.i5.1919.

8.

Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.

Gehrau RC, Mas VR, Dumur CI, Suh JL, Sharma AK, Cathro HP, Maluf DG.

Transplantation. 2015 Dec;99(12):2523-33. doi: 10.1097/TP.0000000000000857.

9.

Declining liver graft quality threatens the future of liver transplantation in the United States.

Orman ES, Mayorga ME, Wheeler SB, Townsley RM, Toro-Diaz HH, Hayashi PH, Barritt AS 4th.

Liver Transpl. 2015 Aug;21(8):1040-50. doi: 10.1002/lt.24160.

10.

Warm ischemic injury is reflected in the release of injury markers during cold preservation of the human liver.

Bruinsma BG, Wu W, Ozer S, Farmer A, Markmann JF, Yeh H, Uygun K.

PLoS One. 2015 Mar 30;10(3):e0123421. doi: 10.1371/journal.pone.0123421. eCollection 2015.

11.

Using old liver grafts for liver transplantation: where are the limits?

Jiménez-Romero C, Caso Maestro O, Cambra Molero F, Justo Alonso I, Alegre Torrado C, Manrique Municio A, Calvo Pulido J, Loinaz Segurola C, Moreno González E.

World J Gastroenterol. 2014 Aug 21;20(31):10691-702. doi: 10.3748/wjg.v20.i31.10691. Review.

12.

Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.

Khullar V, Dolganiuc A, Firpi RJ.

World J Transplant. 2014 Jun 24;4(2):81-92. doi: 10.5500/wjt.v4.i2.81. Review.

13.

Expanded criteria donors.

Feng S, Lai JC.

Clin Liver Dis. 2014 Aug;18(3):633-49. doi: 10.1016/j.cld.2014.05.005. Review.

14.

Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation.

Bruinsma BG, Yeh H, Ozer S, Martins PN, Farmer A, Wu W, Saeidi N, Op den Dries S, Berendsen TA, Smith RN, Markmann JF, Porte RJ, Yarmush ML, Uygun K, Izamis ML.

Am J Transplant. 2014 Jun;14(6):1400-9. doi: 10.1111/ajt.12727. Epub 2014 Apr 23.

15.

Liver Transplantation without Perioperative Transfusions Single-Center Experience Showing Better Early Outcome and Shorter Hospital Stay.

Goldaracena N, Méndez P, Quiñonez E, Devetach G, Koo L, Jeanes C, Anders M, Orozco F, Comignani PD, Mastai RC, McCormack L.

J Transplant. 2013;2013:649209. doi: 10.1155/2013/649209. Epub 2013 Dec 12.

16.

The relationship between preoperative creatinine clearance and outcomes for patients undergoing liver transplantation: a retrospective observational study.

Wenger U, Neff TA, Oberkofler CE, Zimmermann M, Stehberger PA, Scherrer M, Schuepbach RA, Cottini SR, Steiger P, Béchir M.

BMC Nephrol. 2013 Feb 14;14:37. doi: 10.1186/1471-2369-14-37.

17.

Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death.

Orman ES, Barritt AS 4th, Wheeler SB, Hayashi PH.

Liver Transpl. 2013 Jan;19(1):59-68. doi: 10.1002/lt.23547.

18.

Icam-1 upregulation in ethanol-induced Fatty murine livers promotes injury and sinusoidal leukocyte adherence after transplantation.

Theruvath TP, Ramshesh VK, Zhong Z, Currin RT, Karrasch T, Lemasters JJ.

HPB Surg. 2012;2012:480893. doi: 10.1155/2012/480893. Epub 2012 Jun 18.

19.

Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

Subramanian V, Seetharam AB, Vachharajani N, Tiriveedhi V, Angaswamy N, Ramachandran S, Crippin JS, Shenoy S, Chapman WC, Mohanakumar T, Anderson CD.

Transplantation. 2011 Dec 15;92(11):1259-68. doi: 10.1097/TP.0b013e318235a1ab.

20.

Major challenges limiting liver transplantation in the United States.

Wertheim JA, Petrowsky H, Saab S, Kupiec-Weglinski JW, Busuttil RW.

Am J Transplant. 2011 Sep;11(9):1773-84. doi: 10.1111/j.1600-6143.2011.03587.x. Epub 2011 Jun 14. Review.

Supplemental Content

Support Center